Miller Fisher syndrome: A comprehensive review and clinical insights
Синдром Миллера—Фишера: всесторонний обзор и клинические аспекты
2026-03-01
SCID: 54.1/kmuhdwk7
Discuss with AI
Bickerstaff brainstem encephalitisGuillain-Barré syndromeMiller Fisher syndromeanti-ganglioside GQ1b antibodiesmolecular mimicry
Figures from the paper
Abstract (AI)
Miller Fisher syndrome (MFS) is a variant of Guillain-Barré syndrome (GBS), characterized by the clinical triad of ophthalmoplegia, ataxia and areflexia. Anti-ganglioside GQ1b antibodies, detected in 80–90% of cases, play a central role in molecular mimicry-driven pathogenesis. While albuminocytological dissociation in cerebrospinal fluid (CSF) and electrophysiological findings (e.g., sensory axonal neuropathy, absent H-reflex) aid diagnosis, overlap syndromes with GBS or Bickerstaff brainstem encephalitis (BBE) necessitate early recognition to guide management. This review summarize current evidence on MFS pathogenesis, diagnostic challenges, and treatment paradigms, while proposing novel hypotheses on genetic predispositions and calcium-dependent antibody mechanisms.
Key Findings
1
Albuminocytological dissociation in cerebrospinal fluid and electrophysiological findings, including sensory axonal neuropathy and absent H-reflex, support diagnosis.
2
Anti-ganglioside GQ1b antibodies are detected in 80–90% of cases and contribute centrally to molecular mimicry-driven pathogenesis.
3
Miller Fisher syndrome is a Guillain–Barré syndrome variant defined by the triad of ophthalmoplegia, ataxia, and areflexia.
4
Overlap with Guillain–Barré syndrome or Bickerstaff brainstem encephalitis creates diagnostic challenges and makes early recognition important for management.
5
The review proposes novel hypotheses involving genetic predisposition and calcium-dependent antibody mechanisms in Miller Fisher syndrome.
Research Object
Miller Fisher syndrome (MFS)
Research Subject
its clinical features, molecular-mimicry pathogenesis, diagnostic findings and challenges, treatment paradigms, and proposed genetic and calcium-dependent antibody mechanisms
Publication Details
Publication Date
2026-03-01
Journal
Publisher
ISSN
Cited by
2
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest